Role and mechanisms of action ofEscherichia coliNissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial

(2014) Andreas Munk Petersen et al.   Journal of Crohns & Colitis

Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine

(2013) Rosalie Maltby et al.   PLoS One

Probiotics: Properties, Examples, and Specific Applications

(2013) J. Behnsen et al.   Cold Spring Harbor Perspectives in Medicine

Probiotics in the Management of Inflammatory Bowel Disease

(2012) Daisy Jonkers et al.   DRUGS

More than a marine propeller – the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus

(2012) Anja Troge et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

(2011) Wolfgang Kruis et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Probiotics and the gut microbiota in intestinal health and disease

(2010) Mélanie G. Gareau et al.   Nature Reviews Gastroenterology & Hepatology

A probiotic strain ofEscherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice

(2009) B Arribas et al.   BRITISH JOURNAL OF PHARMACOLOGY

Probiotic Escherichia coli Nissle 1917 Versus Placebo for Treating Diarrhea of Greater Than 4 Days Duration in Infants and Toddlers

(2009) Jobst Henker et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

F1C Fimbriae Play an Important Role in Biofilm Formation and Intestinal Colonization by the Escherichia coli Commensal Strain Nissle 1917

(2008) M. A. Lasaro et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Inhibition of growth of Shiga toxin-producingEscherichia coliby nonpathogenicEscherichia coli

(2008) Rolf Reissbrodt et al.   FEMS MICROBIOLOGY LETTERS

Clinical use of E. coli Nissle 1917 in inflammatory bowel disease

(2008) Michael Schultz   INFLAMMATORY BOWEL DISEASES

Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study 

(2008) J Henker et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE